<span item_type="fundamental" item_id="3c5c89a94ba916d380f985398612296d" counter_id="ST/US/NAKAW" env="prod"></span><span item_type="announcement" item_id="584623512483729409" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 388.21 K.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.42.</p><p></p><h3>Segment Revenue</h3><ul><li>Total Revenue for Q3 2025 was $0.4 million, compared to $0.6 million in Q3 2024, reflecting the results of the Company’s healthcare business.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Total operating expenses in Q3 2025 were $10.8 million, up from $1.7 million in Q3 2024, primarily due to increased SG&amp;A costs related to the Company’s Bitcoin strategy.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li><li>Net Loss for Q3 2025 was $86.0 million or - $0.42 per diluted share, compared to $1.0 million or - $0.17 per diluted share in Q3 2024. The net loss was mainly driven by a $59.8 million non-cash charge related to the loss on acquisition of Nakamoto and a $22.1 million non-cash charge related to an unrealized loss on digital assets.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>The report does not provide specific figures for operating cash flow or free cash flow.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>As of September 30, 2025, the Company had purchased a cumulative amount of 5,765 Bitcoin at a weighted average price of $118,204.88 per Bitcoin for approximately $681 million. KindlyMD has utilized 367 Bitcoin for strategic investments and held 5,398 Bitcoin as of November 12, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>KindlyMD aims to compound long-term shareholder value by selectively investing in and acquiring companies that strengthen the broader Bitcoin ecosystem. The company plans to prioritize investments in enterprises aligned with its long-term vision, focusing on disciplined execution and integrating high-quality, cash-generating businesses into a unified Bitcoin operating platform.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1946573/000149315225024314/ex99-1.htm"></span></li></ul>

KINDLY MD INC C/WTS 31/05/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 388.21 K